We wanted to make a study that investigated the effect of growth hormone treatment on metabolism, morphology and quality of life. We were planning a large sample cohort available for analysis, but we couldn’t agree beforehand how to divide and use them.
Suddenly we realized that is wasn’t rational to make the decision now where our knowledge was to limited to make an informed decision – a more practical method had to be possible. We needed a method for preparing for a unknown future of new possibilities
Consequently we came up with the idea of having cryotubes that could be divided in smaller samples without thawing and deteriorating the sample – and the idea of the FlexiQuot was born. Now we don’t have to predict how the biomaterial can or shall be used in the future.
Ove Andersen, FlexiQuot inventor